Pharma
The company said the latest round brings its total raise to $47 million.
The tool uses information about pain level, condition and current medication regimen to find an effective dose of opioids.
The study found only 46% of patients eligible for prophylactic low-dose aspirin due to high-risk factors for preeclampsia had gotten a provider recommendation by 16 weeks gestation.
The partnership expands on the companies’ earlier collaboration announced in late 2019.
As physician workloads in increase, technology is helping providers efficiently connect with pharma reps.
The company is working with Chemist2U's network of local pharmacies to fulfill orders.
This collaboration will work with an unnamed pharma company in Japan to know how its drugs behave compared to rival products.
Also, Medigo raises $1 million to expands its offerings to telemedicine.
Its investment will help the online pharmacy expand its services and bring in additional technology.
This comes ahead of the company's reported IPO filing by October.